Group 1 - China Shipbuilding Defense expects a net profit of 940 million to 1.12 billion yuan for 2025, an increase of 149.61% to 196.88% year-on-year [1] - China First Heavy Industries has only undertaken a small number of related accessory projects and has not generated revenue from them [2] - Huanyu Electronics plans to invest 30 million yuan in a private equity fund focused on AI and emerging industries [3] Group 2 - Zhixiang Jintai's GR1803 injection has been included in the priority review list by the National Medical Products Administration [4] - JianKai Technology's shareholder plans to reduce holdings by up to 3% of the company's shares [5] - Debon Holdings will continue to suspend trading from January 12 due to significant matters being planned [6] Group 3 - South Network Technology's shareholder intends to transfer 847.05 million shares, accounting for 1.50% of the total share capital [7] - Hengrui Medicine has received approval for clinical trials of four drugs [8] - Daotong Technology expects a net profit of 900 million to 930 million yuan for 2025, a year-on-year increase of 40.42% to 45.10% [10] Group 4 - Betta Pharmaceuticals has invested 50 million yuan to acquire a 20% stake in Hangzhou Zhixing Pharmaceutical [11] - Tianyu Biology reported a 10.38% year-on-year decline in cumulative sales revenue for 2025 [12] - Lifang Pharmaceutical's subsidiary has obtained a drug registration certificate for a pain relief product [13] Group 5 - R&F Properties reported a total sales revenue of approximately 14.21 billion yuan for 2025 [14] - Wanfu Biology expects a net profit decline of 87.71% to 91.81% for 2025 [15] - Dazhi expects a negative net profit for 2025 [16] Group 6 - Dongzhu Ecology is negotiating to terminate the acquisition of control over a satellite communication company [17] - Baotai has received a milestone payment of 10 million USD from Hikma Pharmaceuticals [18] - Huace Navigation expects a net profit of 670 million to 690 million yuan for 2025, a year-on-year increase of 14.84% to 18.27% [19] Group 7 - Shenzhen Gas reported a net profit decline of 3.45% for 2025 [20] - Baogang Co. plans to adjust the price of rare earth concentrate for Q1 2026 to 26,834 yuan per ton [21] - Jiuding Investment expects to report a loss for 2025 [22] Group 8 - Shanghai Pharmaceuticals has received a drug registration certificate for a treatment for myasthenia gravis [23] - Hualan Biological plans to acquire a 35% stake in Guangfeng Capsule [24] - Ruina Intelligent plans to invest 169.9 million yuan in a new R&D production base for heat pumps [25] Group 9 - Wantong Development expects to report a loss for 2025 [26] - Xianghe Industrial has completed the purchase of a 5% stake in Hezhixiang Technology [27] - Guangkang Biochemical received a warning letter from the Guangdong Securities Regulatory Commission [28] Group 10 - Xiaoming Co. reported a 37.07% year-on-year decline in chicken product sales revenue for December 2025 [29] - Luokai Co. won a procurement project from State Grid Fujian Power worth approximately 48.2 million yuan [30] - Minhe Co. reported a 65.22% year-on-year increase in the sales of commodity chick seedlings for December 2025 [31] Group 11 - Zhenghai Biological has obtained a registration certificate for calcium silicate bio-ceramic materials [32] - Three Gorges Energy reported a 5.99% year-on-year increase in cumulative total power generation for 2025 [33] - Huisheng Biological expects a net profit of 235 million to 271 million yuan for 2025 [34] Group 12 - Maihe Co. announced the release of the detention measures against its chairman [35] - Wandong's Alzheimer's project has been included in a national major special project for innovative drug development [36] - Kangxin New Materials plans to transfer forest land assets with a book value of 1.203 billion yuan [37] Group 13 - Greenland Holdings expects a net loss of 16 billion to 19 billion yuan for 2025 [39] - Zhongxin Fluorine Materials has obtained a pesticide production license [40]

Core Viewpoint - The company reported significant month-on-month increases in chicken product sales volume and revenue, but year-on-year figures show a decline due to industry challenges such as supply-demand imbalance and low prices [1] Group 1: Sales Performance - In December 2025, the company sold 22.5252 million chickens, generating revenue of 66.0337 million yuan, with month-on-month changes of 18.30% and 41.51% respectively [1] - The average selling price for the month was 2.93 yuan per chicken [1] Group 2: Industry Challenges - Year-on-year sales volume and revenue decreased by 20.37% and 37.07% respectively, indicating significant pressure from the industry [1] - High inventory levels of laying hens have led to notable supply pressure, while market consumption remains weak [1] - Continuous losses in chicken farming and weak pig prices are further suppressing the demand for chicken products [1]

Core Viewpoint - Xiaoming Co., Ltd. (300967.SZ) announced its sales forecast for chicken products in December 2025, projecting sales of 22.5252 million birds and revenue of 66.0337 million yuan, indicating significant changes in sales performance compared to previous periods [1] Group 1: Sales Performance - The company expects to sell 22.5252 million chickens in December 2025, which represents a quarter-on-quarter increase of 18.30% [1] - The projected sales revenue of 66.0337 million yuan shows a quarter-on-quarter increase of 41.51% [1] - Year-on-year comparisons reveal a decrease in sales volume by 20.37% and a revenue decline of 37.07% [1]

Core Viewpoint - The company reported significant month-on-month growth in chicken product sales and revenue for December 2025, but year-on-year comparisons reveal ongoing challenges in the industry due to supply-demand imbalances and low prices [1]. Company Summary - In December 2025, the company sold 22.5252 million chickens, generating sales revenue of 66.0337 million yuan [1]. - Month-on-month changes for sales volume and revenue were 18.30% and 41.51%, respectively [1]. - Year-on-year changes showed a decline in sales volume and revenue of -20.37% and -37.07%, respectively [1]. Industry Summary - The industry continues to face dual pressures from a phase of supply-demand imbalance and persistently low prices [1].

二、原因说明 2025 年 12 月，公司鸡产品销售数量与销售收入环比均实现较大幅度提升。 然而，从同比角度看，行业整体仍受阶段性供需失衡与价格持续低迷的双重压力。 当前，全国在产蛋鸡存栏量依旧处于历史相对高位，供给压力依然显著。尽管春 节前季节性需求提振初步显现，但整体市场消费仍显平淡。与此同时，蛋鸡养殖 持续处于亏损区间，养殖单位对后市预期趋于谨慎，补栏积极性虽略有回暖，但 价格端仍承受较大压力。此外，生猪价格走势偏弱，也从一定程度上抑制了鸡蛋 的替代性消费需求。 证券代码：300967 证券简称：晓鸣股份 公告编号：2026-003 宁夏晓鸣农牧股份有限公司 2025 年 12 月鸡产品销售情况简报 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、2025 年 12 月鸡产品销售情况 宁夏晓鸣农牧股份有限公司（以下简称"公司"）2025 年 12 月销售鸡产品 2,252.52 万羽，销售收入 6,603.37 万元，环比变动分别为 18.30%、41.51%，同 比变动分别为-20.37%、-37.07%。 3、公司指定的信息披露媒体为巨潮资讯网（ ...

证券日报网讯1月6日，晓鸣股份（300967）发布公告称，截至2025年12月31日，公司通过回购专用证券 账户以集中竞价交易方式累计回购股份数量为1，895，100股，占总股本1.0103%，成交区间11.23元/股 至19.18元/股，已支付21，993，238.00元(不含交易费用)。 ...

格隆汇1月6日丨晓鸣股份(300967.SZ)公布，截至2025年12月31日，公司通过回购专用证券账户以集中 竞价交易方式累计回购股份数量为1,895,100股，占公司总股本的1.0103%，成交的最低价格为11.23元/ 股，成交的最高价格为19.18元/股，支付的总金额为人民币21,993,238.00元（不含交易费用）。上述回 购符合公司回购方案及相关法律法规的要求。 ...

每经头条（nbdtoutiao）——原指导价34.99万的宝马裸车价22.5万元，多家车企还补贴购置税！2026开 年车市火爆，销售从早到晚忙到没空吃饭 （记者 王晓波） 每经AI快讯，晓鸣股份1月6日晚间发布公告称，截至2025年12月31日，公司通过回购专用证券账户以 集中竞价交易方式累计回购股份数量约为190万股，占公司总股本的1.0103%，成交的最低价格为11.23 元/股，成交的最高价格为19.18元/股，支付的总金额为人民币约2199万元。 ...

关于回购公司股份的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 宁夏晓鸣农牧股份有限公司（以下简称"公司"）于 2024 年 12 月 20 日召 开第五届董事会第十七次会议、第五届监事会第七次会议，于 2025 年 1 月 10 日召开 2025 年第一次临时股东大会逐项审议通过《关于回购公司股份方案的议 案》，公司将使用自有资金和/或自筹资金通过二级市场以集中竞价交易方式回 购部分公司已在境内发行上市的人民币普通股（A 股）股票，用于实施员工持股 计划或股权激励计划。 本次回购总金额不低于人民币 2,000.00 万元（含）且不超过人民币 4,000.00 万元（含），回购股份的价格不超过 19.74 元/股。具体回购数量以回购期限届 满时实际回购的股份数量为准。本次回购股份的实施期限自公司股东大会审议通 过回购方案之日起 12 个月内。具体内容详见公司 2024 年 12 月 20 日、2025 年 1 月 13 日在巨潮资讯网（http://www.cninfo.com.cn）披露的《关于回购公司股 份方案的公告》(公告编号：2024-13 ...

| 证券代码：300967 | 证券简称：晓鸣股份 | 公告编号：2026-001 | | --- | --- | --- | | 债券代码：123189 | 债券简称：晓鸣转债 | | 宁夏晓鸣农牧股份有限公司 关于 2025 年第四季度可转债转股情况的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 特别提示： 5、转股股份来源：新增股份 根据《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指 引第 2 号——创业板上市公司规范运作》《深圳证券交易所上市公司自律监管指引第 15 号——可转换公司债券》等有关规定，宁夏晓鸣农牧股份有限公司（以下简称"公司"） 现将 2025 年第四季度可转换公司债券（以下简称"可转债"）转股及公司股份变动情况 公告如下： 一、可转换公司债券基本情况 （四）可转换公司债券转股价格的调整 （一）可转换公司债券发行情况 经中国证券监督管理委员会（以下简称"中国证监会"）《关于同意宁夏晓鸣农牧股 份有限公司向不特定对象发行可转换公司债券注册的批复》（证监许可[2023]253 号）同 意注册。宁夏晓鸣农牧股份 ...